Clinical Trial Update: Preoperative Bevacizumab for Vitreous Hemorrhage [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial evaluating preoperative bevacizumab for vitreous hemorrhage in diabetic retinopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy
• Vitreous Hemorrhage

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: University of Sao Paulo | Conditions: Diabetic Retinopathy, Vitreous Hemorrhage | Phase 1, Phase 2 | Status: COMPLETED